Last reviewed · How we verify

PRF is added in the test group.

University of Aarhus · FDA-approved active Biologic

PRF (Platelet-Rich Fibrin) is a biomaterial derived from patient blood that concentrates platelets and growth factors to promote tissue regeneration and healing.

PRF (Platelet-Rich Fibrin) is a biomaterial derived from patient blood that concentrates platelets and growth factors to promote tissue regeneration and healing. Used for Bone and soft tissue regeneration in dental and oral surgery, Wound healing and tissue repair, Orthopedic and maxillofacial applications.

At a glance

Generic namePRF is added in the test group.
SponsorUniversity of Aarhus
Drug classRegenerative medicine / Biomaterial
ModalityBiologic
Therapeutic areaRegenerative Medicine / Wound Healing / Dentistry / Orthopedics
PhaseFDA-approved

Mechanism of action

PRF is prepared by centrifuging whole blood to separate and concentrate platelets, leukocytes, and fibrin into a matrix. When applied to tissue defects, it releases growth factors (PDGF, VEGF, TGF-β) and cytokines that stimulate angiogenesis, collagen deposition, and cellular proliferation, accelerating wound healing and tissue repair.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results